Reuters
@Reuters·4.2M subscribers·86.9K videos
Kimberly-Clark bets $40 billion on Kenvue despite Tylenol controversy | REUTERS
Posted
November 3, 2025
Views
1,512
Likes
22
Engagement
1.46%
November 3, 2025
1,512
22
1.46%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
1:48Now PlayingKimberly-Clark will buy Tylenol maker Kenvue for more than $40 billion in a historic deal that comes as the smaller company faces lawsuits over the painkiller, White House attacks and choppy demand.
#News #Reuters #Newsfeed #kimberlyclark #kenvue #tylenol
Read the story here
👉 Subscribe
Keep up with the latest news from around the world
Follow Reuters on Facebook
Follow Reuters on Twitter
Follow Reuters on Instagram
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
